Last checked at 
Welcome to the home for real-time coverage of markets brought to
you by Reuters reporters. You can share your thoughts with us at
markets.research@thomsonreuters.com
EUROPE’S STOCKS EDGE LOWER AFTER A STRONG WEEK (0838 GMT)
European stocks are slightly lower after a weak start of the
day as Italy and France registered record numbers of COVID-19
cases. Pandemic worries were, however, partly offset by a batch
of stronger than expected results.
The STOXX 600 is now down 0.4% and set to post its best week
since June as of now, with insurers outperforming up 0.6% after
Allianz reported an unexpected rise in Q3 profit.
Travel and leisure stock and tech stock
indexes are the worst performers respectively down 1% and 0.9%.
In terms of single stocks, Richemont shares are up
10% after the company said it sees a marked improvement in the
second quarter thanks to online retail sales and China.
(Stefano Rebaudo)
*****
ON THE RADAR: ALLIANZ, RICHEMONT, RSA (0740 GMT)
European stocks are poised to open lower after a 5-day rally
as focus is back on the economic impact of the virus, while
investors are waiting for final results of the U.S. elections.
Yet, a batch of stronger than expected corporate results is
providing some support to European equities.
Allianz stocks are up 2.1% in premarket trade
after the company posted an unexpected 6% rise in net profit in
the third quarter, at 1.947 billion euros, higher than 1.626
billion euro consensus forecast.
Shares in Richemont are indicated up 4% as the
company sees a marked improvement in the second quarter thanks
to online retail sales and China. The Cartier jewellery maker's
net profit fell 82% in the six months to Sept. 30.
On the back of Richemont, Swatch shares are up 2.75%
in premarket trade.
Freenet, Rheinmetall and Deutsche
Telekom shares are up respectively 1.6%, 1.8% and
1.9% after results.
Bullish news also on the M&A front, with RSA Insurance Group
in talks with a consortium of Canadian insurer Intact
Financial and Danish insurer Tryg about a
possible break-up deal that values the British firm at about 7.2
billion pounds ($9.46 billion).
Shares in Bilfinger are up 9.8% in premarket trade
on a press report that the company decided to explore a sale
after receiving takeover interest.
British industrial software provider Aveva Group
intends to raise 2.84 billion pounds through a rights issue to
partly fund the acquisition of SoftBank-backed peer OSIsoft.
In the vaccine front, AstraZeneca plans to start
early and mid-stage clinical trials of its COVID-19 vaccine
candidate in China this year as it prepares a global rollout.
Novartis's canakinumab failed to help COVID-19
patients survive without invasive ventilation compared with
standard therapy, dashing hopes the arthritis drug could be
repurposed during the pandemic.
Seven municipalities in northern Denmark imposed a hard
lockdown, while Britain said it is removing Denmark
from the government's travel corridor list. Paris
will be placed under more restrictions, Greece
ordered a nationwide lockdown for three weeks.
As a result, British airline easyJet said it will
fly no more than 20% of capacity for the rest of the year.
(Stefano Rebaudo and Joice Alves)
*****
EUROPE IN THE RED AFTER 5-DAY WINNING STREAK (0633 GMT)
European stock futures are in the red along with their U.S.
peers after a 5-day rally, but an expected political gridlock in
the U.S. props up risk sentiment.
Investors have been betting on a Republican controlled
Senate that would block any moves to tighten regulation and
raise taxes.
But their focus is now back on the economic impact of new
lockdowns in Europe to contain the pandemic and a U.S. fiscal
stimulus which could be way smaller than expected.
In the battleground states of Georgia and Pensylvania there
is not a clear winner of the presidential elections yet.
(Stefano Rebaudo)
*****
